New possibilities how to treat SLE-belimubab.Commentary on:Lancet 377,2011,721-731

Abstract

Systemic lupus erythematosus, belimumab, SELENA - SLEDAI, B lymphocytes, multisystemic autoimmune disease, mortality

Keywords

• Systemic lupus erythematosus
• belimumab, SELENA - SLEDAI
• B lymphocytes
• multisystemic autoimmune disease
• mortality